Literature DB >> 27654163

Comparison of clinical signs and outcomes between dogs with presumptive ischemic myelopathy and dogs with acute noncompressive nucleus pulposus extrusion.

Joe Fenn, Randi Drees, Holger A Volk, Steven De Decker.   

Abstract

OBJECTIVE To compare clinical signs and outcomes between dogs with presumptive ischemic myelopathy and dogs with presumptive acute noncompressive nucleus pulposus extrusion (ANNPE). DESIGN Retrospective study. ANIMALS 51 dogs with ischemic myelopathy and 42 dogs with ANNPE examined at 1 referral hospital. PROCEDURES Medical records and MRI sequences were reviewed for dogs with a presumptive antemortem diagnosis of ischemic myelopathy or ANNPE. Information regarding signalment, clinical signs at initial examination, and short-term outcome was retrospectively retrieved from patient records. Long-term outcome information was obtained by telephone communication with referring or primary-care veterinarians and owners. RESULTS Compared with the hospital population, English Staffordshire Bull Terriers and Border Collies were overrepresented in the ischemic myelopathy and ANNPE groups, respectively. Dogs with ANNPE were significantly older at disease onset and were more likely to have a history of vocalization at onset of clinical signs, have spinal hyperesthesia during initial examination, have a lesion at C1-C5 spinal cord segments, and be ambulatory at hospital discharge, compared with dogs with ischemic myelopathy. Dogs with ischemic myelopathy were more likely to have a lesion at L4-S3 spinal cord segments and have long-term fecal incontinence, compared with dogs with ANNPE. However, long-term quality of life and outcome did not differ between dogs with ischemic myelopathy and dogs with ANNPE. CONCLUSIONS AND CLINICAL RELEVANCE Results revealed differences in clinical signs at initial examination between dogs with ischemic myelopathy and dogs with ANNPE that may aid clinicians in differentiating the 2 conditions.

Entities:  

Mesh:

Year:  2016        PMID: 27654163     DOI: 10.2460/javma.249.7.767

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  8 in total

1.  Magnetic resonance imaging muscle lesions in presumptive canine fibrocartilaginous embolic myelopathy.

Authors:  Sabrina M Martens; Stephanie G Nykamp; Fiona M K James
Journal:  Can Vet J       Date:  2018-12       Impact factor: 1.008

2.  Influence of Spinal Shock on the Neurorehabilitation of ANNPE Dogs.

Authors:  Débora Gouveia; Ana Cardoso; Carla Carvalho; Ana Rita Gonçalves; Óscar Gamboa; Rute Canejo-Teixeira; António Ferreira; Ângela Martins
Journal:  Animals (Basel)       Date:  2022-06-16       Impact factor: 3.231

3.  Pathological changes within two weeks following spinal cord injury in a canine model.

Authors:  Yuya Nakamoto; Gentarou Tsujimoto; Akito Ikemoto; Koichi Omori; Tatsuo Nakamura
Journal:  Eur Spine J       Date:  2021-07-20       Impact factor: 3.134

Review 4.  Bladder and Bowel Management in Dogs With Spinal Cord Injury.

Authors:  Nicolas Granger; Natasha J Olby; Yvette S Nout-Lomas
Journal:  Front Vet Sci       Date:  2020-11-11

Review 5.  Prognostic Factors in Canine Acute Intervertebral Disc Disease.

Authors:  Natasha J Olby; Ronaldo C da Costa; Jon M Levine; Veronika M Stein
Journal:  Front Vet Sci       Date:  2020-11-26

6.  Predictors of urinary or fecal incontinence in dogs with thoracolumbar acute non-compressive nucleus pulposus extrusion.

Authors:  Lorenzo Mari; Sebastien Behr; Anita Shea; Elisabet Dominguez; Cristoforo Ricco; Emili Alcoverro; Abel Ekiri; Daniel Sanchez-Masian; Luisa De Risio
Journal:  J Vet Intern Med       Date:  2019-10-31       Impact factor: 3.333

Review 7.  Diagnostic Imaging in Intervertebral Disc Disease.

Authors:  Ronaldo C da Costa; Steven De Decker; Melissa J Lewis; Holger Volk
Journal:  Front Vet Sci       Date:  2020-10-22

8.  Preliminary study of presumptive intradural-intramedullary intervertebral disc extrusion in 20 dogs.

Authors:  Jaehwan Kim; Hyoju Kim; Jeongyeon Hwang; Kidong Eom
Journal:  J Vet Sci       Date:  2020-07       Impact factor: 1.672

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.